COMMUNIQUÉS West-GlobeNewswire

Imagin Gains Momentum; Positive Progress in Research Study
26/04/2018
VANCOUVER, British Columbia and BOSTON, April 26, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTC PINK:IMEXF) (Frankfurt & Stuttgart Symbol:DPD2) (the “Company”) is providing the following update on the [...]
Histogenics Corporation to Report First Quarter 2018 Financial Results on May 10, 2018
26/04/2018
WALTHAM, Mass., April 26, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX ), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored function, [...]
Navamedic ASA: Strengthens international IP position with two new patents in the U.S.
26/04/2018
Oslo, 26 April 2018 - Navamedic ASA announced today that the United States Patent and Trademark Office has granted patents for the Sippi® base technology for using capacitance as a volume measurement and silicone oil as [...]
PolarityTE Leadership to Participate in the Symposium on Advanced Wound Care
26/04/2018
SALT LAKE CITY, April 26, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq: COOL ) today announced attendance and participation in the Symposium on Advanced Wound Care Spring (SAWC Spring) Wound Healing Society (WHS) [...]
Aino Health AB (publ): Aino Health gains representation in the United Arab Emirates
26/04/2018
April 26, 2018 Aino Health gains representation in the United Arab Emirates Aino Health has entered into an exclusive partnership agreement with Emirates Artificial Intelligence Technologies LLC. Emirates A.I. as the [...]
Achaogen Wins CARB-X Funding Award to Advance Development of Novel Aminoglycoside to Fight Highly-Resistant Infections
26/04/2018
-- CARB-X funding to support Achaogen’s early-stage aminoglycoside program developing antibiotics for difficult to treat infections that are associated with high mortality -- -- Awarded Up to $2.4 million over appr [...]
Rexahn to Present Clinical Data at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
26/04/2018
Preliminary Safety and Efficacy Data from Phase 1b/2a Trial of RX-5902 in Advanced Triple Negative Breast Cancer Updated Safety and Efficacy Data on RX-3117 in Advanced Urothelial (Bladder) Cancer ROCKVILLE, Md., April [...]
PositiveID’s Chairman and CEO Addresses Stockholders
26/04/2018
DELRAY BEACH, Fla., April 26, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSIDD), a life sciences company focused on detection and diagnostics, announced today that its Chairman and [...]
Aduro Biotech Presents Early Observations From its Personalized Neoantigen-based pLADD Therapy Clinical Study at European Neoantigen Summit
26/04/2018
pLADD Therapy Found to Induce Both Innate and Adaptive Immunity BERKELEY, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq: ADRO ) today presented preliminary observations from a case study of a [...]
Tauriga Sciences Inc. Announces Cancellation of Final Remaining Back-End Convertible Debenture Held by GS Capital Partners LLC in Connection with the $105,000 Face Value 8% Convertible Debenture Dated October 17, 2017
26/04/2018
NEW YORK, NY, April 26, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary [...]
BioNovelus Receives Organic Certification for CR-10®
26/04/2018
FOR IMMEDIATE RELEASE — Phoenix, April 26, 2018 (GLOBE NEWSWIRE) -- — BioNovelus is proud to announce that its flagship product CR-10®, a non-toxic, organic fungicide has received the organic certification from Mayacert [...]
INSYS Therapeutics and University of California (UC) San Diego Center for Medicinal Cannabis Research to Collaborate on Clinical Trial
26/04/2018
Company’s pharmaceutical-grade cannabidiol (CBD) oral solution will be evaluated by UC San Diego/CMCR researchers as potential treatment for symptoms of autism PHOENIX, April 26, 2018 (GLOBE NEWSWIRE) -- NSYS [...]
Krystal Biotech Announces FDA Clearance of IND on KB103 to Begin Enrolling Patients for the Treatment of Dystrophic Epidermolysis Bullosa
26/04/2018
KB103 is the first-ever herpes simplex virus ( HSV-1) based topical gene therapy candidate engineered to produce human collagen protein to treat dystrophic epidermolysis bullosa (DEB) The planned Phase 1/2 KB103 single [...]
Poseida Therapeutics Presents Clinical Manufacturing Method for Durable, Persistent CAR-T Stem Cell Memory Therapies at World Orphan Drug Congress USA
26/04/2018
SAN DIEGO, April 26, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc., a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, provided an overview of its non- [...]
The Joint Corp. to Host Conference Call on Thursday, May 10, to Discuss First Quarter 2018 Results
26/04/2018
SCOTTSDALE, Ariz., April 26, 2018 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT ), a national operator, manager and franchisor of chiropractic clinics, announced it will report its first quarter 2018 financial [...]
CrownBio Launches New Humanized Target Model for Immunotherapy
26/04/2018
SAN DIEGO, April 26, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing [...]
BioSig Technologies to Partner with High Lantern Group
26/04/2018
Leading global communication experts to lend support to BioSig’s growth strategy Santa Monica, CA, April 26, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a [...]
AMAG Pharmaceuticals to Host First Quarter 2018 Financial Results Conference Call and Webcast on Thursday, May 3, 2018 at 8:00 a.m. ET
26/04/2018
WALTHAM, Mass., April 26, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced that its first quarter 2018 financial results will be released on Thursday, May 3, 2018 before the U.S. [...]
Corbus Pharmaceuticals to Present at the Deutsche Bank 43rd Annual Health Care Conference
26/04/2018
Live audio presentation and webcast on Wednesday, May 9th at 11:20 a.m. EDT NORWOOD, Mass., April 26, 2018 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP ) ("Corbus" or the "Company"), a [...]

Pages